Safety of long-term prophylaxis with BAY 94-9027: interim results of >5 years of treatment in the PROTECT VIII extension trial - Reding, M T; Ng, H J; Tseneklidou-Stoefer, D; Linardi, C; Laelzari, S (Haemophilia, 2018)
(S5):